NOAH Compendium

Printed from NOAH Compendium (http://www.noahcompendium.co.uk). (c) Copyright NOAH Compendium 2021. All Rights Reserved.
Date: Wednesday, April 21, 2021 2:51

Release 2.89
Noromectin 1% w/v Multi Injection Solution for Injection
 
Species: Cattle, Pigs, Sheep
Therapeutic indication: Pharmaceuticals: Endoparasiticides: Anthelmintics for sheep, Anthelmintics for goats, Anthelmintics for pigs, For cattle, For sheep, For pigs, For cattle, For sheep, For pigs
Active ingredient: Ivermectin
Product:Noromectin 1% w/v Multi Injection Solution for Injection
Product index: Noromectin Multi Injection
Cattle - milk: See notes
Cattle - meat: 49 days
Sheep - meat: 42 days
Pig - meat: 28 days
Withdrawal notes: Not to be used in animals producing milk for human consumption. Do not use in non-lactating dairy cows, including pregnant heifers within 60 days of calving.
Qualitative and quantitative composition
Active substance(s):
Ivermectin
1.0% w/v (10 mg in 1 ml)
Excipients:
For a full list of excipients, see section Pharmaceutical Particulars
Pharmaceutical form
Solution for injection.
A clear colourless to pale yellow, slightly viscous, sterile non-aqueous solution.
Clinical particulars
Target Species
Beef and non-lactating dairy cattle, sheep and pigs.
Indications for Use, Specifying the Target Species
Cattle
For the treatment and control of the following species of gastrointestinal roundworms, lungworms, eyeworms, warbles, mites and sucking lice in beef cattle and non-lactating dairy cattle.
Gastrointestinal roundworms (adults and fourth stage larvae):
Ostertagia ostertagi (including inhibited O ostertagi), Ostertagia lyrata, Haemonchus placei, Trichostrongylus axei, Trichostrongylus colubriformis, Cooperia oncophora, Cooperia punctata, Cooperia pectinata, Bunostomum phlebotomum, Oesophagostomum radiatum, Strongyloides papillosus (adult), Nematodirus helvetianus (adult), Nematodirus spathiger (adult), and Trichuris spp (adults)
Lungworms (adult and fourth stage larvae):
Dictyocaulus viviparus
Eyeworms (adult):
Thelazia spp
Warbles (parasitic stages):
Hypoderma bovis, Hypoderma lineatum
Sucking Lice:
Linognathus vituli, Haematopinus eurysternus, Solenopotes capillatus
Mange Mites:
Psoroptes bovis, Sarcoptes scabiei var bovis
The product may also be used as an aid in the control of the biting louse Damalinia bovis and the mange mite Chorioptes bovis, but complete elimination may not occur.
Sheep
For the treatment and control of psoroptic mange (sheep scab), gastrointestinal nematodes, lungworms and nasal bots of sheep.
At the recommended dosage level of 200 mcg ivermectin per kg bodyweight the product effectively controls the following parasites of sheep:
Gastrointestinal roundworms (adults and fourth stage larvae):
Teladorsagia circumcincta, O. trifurcata, Haemonchus contortus, Trichostrongylus axei (adults), Trichostrongylus colubriformis, Trichostrongylus vitrinus (adults), Cooperia curticei, Oesophagostomum venulosum, Oesophagostomum columbianum, Nematodirus filicollis, Chabertia ovina, Trichuris ovis (adults)
Inhibited larval stages and benzimidazole resistant strains of Haemonchus contortus and Teladorsagia circumcincta are also controlled.
Lungworms:
Dictyocaulus filaria (adults and fourth stage larvae), Protostrongylus rufescens (adults).
Mange Mites:
Psoroptes ovis
Nasal Bot:
Oestrus ovis (all larval stages)
Pigs
For the treatment and control of the harmful species of gastrointestinal roundworms, lungworms, lice and mange mites of pigs. At the recommended dose rate of 300 μg/kg the product provides effective control of the following parasites:
Gastrointestinal worms:
Ascaris suum (adults and fourth-stage larvae)
Hyostrongylus rubidus (adults and fourth-stage larvae)
Oesophagostomum spp (adults and fourth-stage larvae)
Strongyloides ransomi (adults and somatic larval stages)
Lungworms:
Metastrongylus spp (adults)
Lice:
Haematopinus suis
Mange Mites:
Sarcoptes scabiei var suis
The product may also be used as an aid in the control of adult whipworm (Trichuris suis).
Contraindications
The product is for administration only by the subcutaneous route and must not be given via other routes. It should not be used in other species than those indicated as severe reactions, including fatalities in dogs, may occur.
Special Warnings for Each Target Species
Immediately following subcutaneous injection, activity suggesting pain, sometimes intense but usually transient, has been observed in some sheep.
Special Precautions for Use
Care should be taken to avoid the following practices because they increase the risk of development of resistance and could ultimately result ineffective therapy:
Too frequent and repeated use of anthelmintics from the same class, over an extended period of time.
Underdosing, which may be due to underestimation of body weight, misadministration of the product, or lack of calibration of the dosing device (if any).
Suspected clinical cases of resistance to anthelmintics should be further investigated using appropriate tests (e.g. Faecal Egg Count Reduction Test). Where the results of the test(s) strongly suggest resistance to a particular anthelmintic, an anthelmintic belonging to another pharmacological class and having a different mode of action should be used.
Resistance to ivermectin (an avermectin) has been reported in Telodorsagia in sheep and goats within the EU and it is common in Haemonchus in sheep outside the EU. It has been reported in Cooperia oncophora in cattle within the EU, in Teladorsagia in cattle in developed countries such as New Zealand and Haemonchus outside the EU. Therefore the use of this product should be based on local (regional, farm) epidemiological information about the susceptibility of nematodes and recommendations on how to limit further selection for resistance to anthelmintics.
Special precautions for use in animals
In pigs, especially those under 16 kg for which less than a volume of 0.5 ml is indicated, dosing accuracy is important. The use of a suitably calibrated syringe that can accurately deliver 0.1 ml is recommended.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Do not eat, drink or smoke while handling the product.
Direct contact of the product with the skin should be kept to a minimum. Wash hands after use.
Take care to avoid accidental self-injection: this product may cause local irritation and/or pain at the injection site.
Adverse Reactions (Frequency and Seriousness)
Transitory discomfort has been observed in some cattle following subcutaneous administration. Tissue swellings at the injection site have been observed. These reactions resolve without treatment.
See also section, "Overdose (symptoms, emergency procedures, antidotes), if necessary"
Use During Pregnancy, Lactation or Lay
The product can be administered to beef cows and ewes at any stage of pregnancy or lactation.
The product can be administered to sows at any stage of pregnancy or lactation.
Interaction with Other Medicinal Products and Other Forms of Interaction
None identified.
Amounts to be Administered and Administration Route
To ensure administration of a correct dose, body weight should be determined as accurately as possible; accuracy of the dosing device should be checked.
Cattle
Ivermectin should be administered at a dosage rate of 200 *g per kg bodyweight (1 ml to 50 kg bodyweight). It should only be injected subcutaneously in front of or behind the shoulder using aseptic technique. A sterile 17 gauge x ½ inch needle is recommended.
Sheep
Administer only by subcutaneous injection in the neck at the recommended dosage level of 200 μg ivermectin per kg bodyweight using aseptic technique. Each ml contains 10 mg ivermectin to treat 50 kg of bodyweight. Swab the septum before removing each dose. Use a dry sterile needle and syringe.
Administer subcutaneously only. Inject once under the loose skin in the neck. For the treatment and control of sheep scab (Psoroptes ovis) two injections with a seven day interval are required to treat clinical signs of scab and eliminate living mites. Use of a 17 gauge x ½ inch (15-20 mm) needle is suggested. Replace with a fresh sterile needle after every 10-12 animals. Injection of wet or dirty animals is not recommended.
When treating sheep of less than 16 kg seek veterinary advice regarding the use of 1 ml disposable syringes graduated in increments of 0.1 ml.
For the treatment of individual sheep a syringe not exceeding 2.0 ml and calibrated in increments of 0.1 ml should be used.
Pigs
Administer at a dosage rate of 300 µg per kg bodyweight (1 ml per 33 kg). The product should be injected subcutaneously into the neck using aseptic technique. A sterile 17 gauge x ½ inch needle is recommended.
This product does not contain an antimicrobial preservative. Swab septum before removing each dose. Use a dry sterile needle and syringe. For 250 ml, 500 ml and 1 litre pack sizes, use of a multiple dose syringe is recommended. To refill the syringe, use of a draw-off needle is recommended to avoid excessive broaching of the stopper. Avoid introduction of contamination.
Overdose (symptoms, emergency procedures, antidotes), if necessary
Cattle
Single doses of 4.0 mg/kg ivermectin (20 times the recommended dosage) administered subcutaneously, results in ataxia and depression. No antidote has been identified. Symptomatic treatment may be beneficial.
Sheep
Dose levels of up to 4mg/kg given subcutaneously can result in ataxia and depression. Symptomatic treatment may be beneficial.
Pigs
Ivermectin has a recognised wide safety margin and is known to be safe in all ages of swine. It has no adverse effects on fertility in sows or breeding performance of boars.
Clinical signs of ivermectin toxicity in swine include tremors, bilateral mydriasis and recumbency with some biochemical abnormalities including a transient depression of serum iron. Such changes were only observed when ivermectin was administered subcutaneously at a dose of 30 mg/kg (100 times the normal therapeutic dose).
Withdrawal Period
Cattle:
Must not be slaughtered for human consumption until 49 days after the last treatment.
This product should not be used in cattle producing milk for human consumption. The product should not be used in non-lactating dairy cows including pregnant heifers within 60 days of calving.
Sheep:
Must not be slaughtered for human consumption until 42 days after the last treatment.
This product should not be used in lactating ewes producing milk for human consumption.
Pigs:
Must not be slaughtered for human consumption until 28 days after the last treatment.
Pharmacological particulars
Pharmacotherapeutic group: Anthelmintic
ATC Vet Code: QP 54 AA 01
Pharmacodynamic Properties
Ivermectin is a 22,23-dihydro derivative of an avermectin (which is a fermentation product produced by Streptomyces avermitilis) and consists of 2 homologues: B1a and B1b. It is a parasiticide with nematocidal, insecticidal and acaricidal activity documented in a wide range of domesticated animals.
Ivermectin is a member of the macrocyclic lactone class of endectocides which have a unique mode of action. Compounds of this class bind selectively and with high affinity to glutamate gated chloride ion channels which occur in invertebrate nerve and muscle cells. This leads to an increase in the permeability of the cell membrane to chloride ions with the hyper-polarisation of the nerve or muscle cell resulting in paralysis and death of the parasite.
Compounds of this class may also interact with other ligand-gated chloride channels, such as those gated by the neurotransmitter gamma-aminobutyric acid (GABP).
The margin of safety for compounds of this class is attributable to the fact that mammals do not have glutamate gated chloride channels, the macrocyclic lactone have a low affinity for other mammalian ligand-gated chloride channels and they do not readily cross the blood-brain barrier.
Pharmaceutical particulars
List of Excipients
Glycerol Formal
Macrogol 200
Incompatibilities
None known.
Shelf-Life
Shelf life of the veterinary medicinal product as packaged for sale: 2 years.
Shelf life after first opening the immediate packaging: 28 days.
Special Precautions for Storage
Do not store above 25°C.
Protect from light.
Discard unused material.
Following withdrawal of the first dose, use the product within 28 days.
This product does not contain an antimicrobial preservative.
Swab the septum before removing each dose.
Use a dry sterile needle and syringe.
Avoid the introduction of contamination.
When using the 250 ml, 500 ml and 1 litre pack sizes, use only automatic syringe equipment. To refill the syringe use of a draw off needle is recommended to avoid excess broaching of the stopper.
Nature and Composition of Immediate Packaging
50 ml, 100 ml, 250 ml, 500 ml and 1 litre high-density polyethylene vials with bromobutyl bungs and aluminium overseals.
Not all pack sizes may be marketed.
Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
Any unused product or waste material should be disposed of in accordance with national requirements.
EXTREMELY DANGEROUS to fish and aquatic life. Do not contaminate ponds, waterways or ditches with the product or used container.
Marketing Authorisation Holder (if different from distributor)
Norbrook Laboratories Limited
Station Works
Camlough Road
Newry
Co. Down
BT35 6JP
Northern Ireland
Marketing Authorisation Number
Vm 02000/4174
Significant changes
Date of the first authorisation or date of renewal
20th October 1999
Date of revision of the text
December 2009
Any other information
Nil.
Legal category
Legal category: POM-VPS
GTIN
GTIN description:Noromectin Multi Inj (50ml)
GTIN:5023534003410
GTIN description:Noromectin Multi Inj (100ml)
GTIN:5023534003427
GTIN description:Noromectin Multi Inj: 250ml
GTIN:5023534003434
GTIN description:Noromectin Multi Inj (500ml)
GTIN:5023534003441